Literature DB >> 19652169

Cases: Charles Bonnet syndrome: visual loss and hallucinations.

M L Jackson1, Joseph Ferencz.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19652169      PMCID： PMC2717672          DOI： 10.1503/cmaj.090049

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  13 in total

1.  Charles Bonnet, his life, and his syndrome.

Authors:  Thomas R Hedges
Journal:  Surv Ophthalmol       Date:  2007 Jan-Feb       Impact factor: 6.048

2.  Successful treatment of hallucinations associated with sensory impairment using gabapentin.

Authors:  Suzanne Holroyd; Samia Sabeen
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2008       Impact factor: 2.198

3.  Olanzapine therapy in hallucinatory visions related to Bonnet syndrome.

Authors:  M Coletti Moja; E Milano; S Gasverde; M Gianelli; M T Giordana
Journal:  Neurol Sci       Date:  2005-07       Impact factor: 3.307

4.  Charles Bonnet syndrome with auditory hallucinations: a diagnostic dilemma.

Authors:  H Hori; T Terao; J Nakamura
Journal:  Psychopathology       Date:  2001 May-Jun       Impact factor: 1.944

5.  A three-year follow-up study of visual hallucinations in patients with macular degeneration.

Authors:  S Holroyd; P V Rabins
Journal:  J Nerv Ment Dis       Date:  1996-03       Impact factor: 2.254

6.  Cisapride in the treatment of visual hallucinations caused by vision loss: the Charles Bonnet syndrome.

Authors:  N G Ranen; R E Pasternak; B W Rovner
Journal:  Am J Geriatr Psychiatry       Date:  1999       Impact factor: 4.105

7.  Treatment of Charles Bonnet syndrome with valproate.

Authors:  H Hori; T Terao; Y Shiraishi; J Nakamura
Journal:  Int Clin Psychopharmacol       Date:  2000-03       Impact factor: 1.659

Review 8.  Complex visual hallucinations in the visually impaired: the Charles Bonnet Syndrome.

Authors:  G Jayakrishna Menon; Imran Rahman; Sharmila J Menon; Gordon N Dutton
Journal:  Surv Ophthalmol       Date:  2003 Jan-Feb       Impact factor: 6.048

9.  Visual hallucinations during prolonged blindfolding in sighted subjects.

Authors:  Lotfi B Merabet; Denise Maguire; Aisling Warde; Karin Alterescu; Robert Stickgold; Alvaro Pascual-Leone
Journal:  J Neuroophthalmol       Date:  2004-06       Impact factor: 3.042

10.  Ophthalmologic features of Parkinson's disease.

Authors:  V Biousse; B C Skibell; R L Watts; D N Loupe; C Drews-Botsch; N J Newman
Journal:  Neurology       Date:  2004-01-27       Impact factor: 9.910
View more
  2 in total

1.  A low dose of risperidone resolved Charles Bonnet syndrome after an unsuccessful trial of quetiapine: a case report.

Authors:  Sultan H Alamri
Journal:  Neuropsychiatr Dis Treat       Date:  2018-03-20       Impact factor: 2.570

Review 2.  Hallucinations Experienced by Visually Impaired: Charles Bonnet Syndrome.

Authors:  Linda Pang
Journal:  Optom Vis Sci       Date:  2016-12       Impact factor: 1.973
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.